HONG KONG -- Chinese venture capital firm Alwin Capital said it has secured the final close of a dual-currency fund at $300 million to invest in life and interdisciplinary sciences.
DealStreetAsia
China medical investor Alwin Capital closes fund at $300m
Firm specializes in life science investments such as medical robots, equipment
Founded in 2015, Alwin Capital invests in life science companies and has secured the final close of a dual-currency fund.
Read Next
Latest on DealStreetAsia
